Lee's Pharmaceutical Holdings Ltd represents a set of core values and a corporate philosophy that guide its operations. The company focuses on excellence, innovation, and integrity, striving to deliver high-quality pharmaceutical products and services to enhance patients' well-being. Upholding a patient-centric approach, Lee's Pharmaceutical aims to improve the accessibility and affordability of healthcare solutions while maintaining a strong commitment to ethical practices and compliance. With a dedication to research and development, the company continuously seeks innovative solutions to address unmet medical needs. As a responsible corporate entity, Lee's Pharmaceutical actively contributes to society by supporting various philanthropic initiatives.

Lee's Pharmaceutical Holdings Ltd is primarily present in the markets of China and Hong Kong. With its headquarters in Hong Kong, the company has established a strong presence in these regions. Lee's Pharmaceutical Holdings Ltd focuses on the research, development, manufacturing, and sales of innovative pharmaceutical products, catering to the healthcare needs of the local population. Through strategic partnerships and collaborations, Lee's Pharmaceutical Holdings Ltd continues to expand its footprint in China and Hong Kong, contributing to the growth of the healthcare industry in these regions.

Lee's Pharmaceutical Holdings Ltd has achieved significant milestones over the years. The company has successfully developed and launched numerous innovative products in the pharmaceutical industry. One of its notable achievements includes the successful development of a drug for the treatment of hepatocellular carcinoma, a type of liver cancer. Lee's Pharmaceutical Holdings Ltd has also established partnerships and collaborations with leading global pharmaceutical companies, further expanding its reach and facilitating the development and distribution of its products. Additionally, the company has received various awards and recognitions for its contributions to the healthcare sector, highlighting its commitment to excellence and innovation.

Lee's Pharmaceutical Holdings Ltd is a leading pharmaceutical company established in 1994. With a primary focus on developing, manufacturing, and marketing innovative drug products, the company has achieved significant success over the years. Lee's Pharma has built a strong reputation for its expertise in areas such as oncology, cardiovascular, dermatology, and respiratory diseases. Through continuous research and strategic collaborations, the company has expanded its product portfolio and gained recognition both domestically and internationally. Lee's Pharmaceutical Holdings Ltd has consistently demonstrated commitment to improving patients' lives by providing effective and safe medications.

Some of the main competitors of Lee's Pharmaceutical Holdings Ltd in the market include Ascentage Pharma Group, China Grand Pharmaceutical and Healthcare Holdings Limited, and Hutchison China MediTech Ltd. These companies operate in the pharmaceutical industry and provide similar products and services as Lee's Pharmaceutical Holdings Ltd.

Lee's Pharmaceutical Holdings Ltd is primarily active in the pharmaceutical industry.

The business model of Lee's Pharmaceutical Holdings Ltd revolves around the development, manufacturing, and commercialization of pharmaceutical products. As a reputable pharmaceutical company, Lee's Pharmaceutical Holdings Ltd focuses on research and development to bring innovative and high-quality drugs to the market. They strive to address unmet medical needs and improve patient outcomes by collaborating with global partners and investing in cutting-edge technology. Lee's Pharmaceutical Holdings Ltd aims to provide effective and affordable healthcare solutions, making a significant contribution to the pharmaceutical industry's advancements.

مُعامل القيمة السوقية إلى الأرباح لـ Lee's Pharmaceutical Holdings هو ٨٫١١.

مُعامِل القيمة إلى المبيعات Lee's Pharmaceutical Holdings هو ٠٫٥٤.

نقاط جودة AlleAktien لـ Lee's Pharmaceutical Holdings هي 3/10.

المتوقعة Lee's Pharmaceutical Holdings الإيرادات هي ١٫٢٩ مليارات HKD.

صافي الربح المتوقعة Lee's Pharmaceutical Holdings هو ٨٥٫٦٤ مليون. HKD.

Lee's Pharmaceutical Holdings Limited is a leading biopharmaceutical company specializing in the development, manufacturing, and marketing of innovative drugs and medical products in China and internationally. The company is headquartered in Hong Kong and operates branches and production facilities on the Chinese mainland.

يوزع Lee's Pharmaceutical Holdings أرباحًا قدرها ٠٫٠٤ HKD من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Lee's Pharmaceutical Holdings في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـLee's Pharmaceutical Holdings هو KYG5438W1116.

رمز WKN لـ Lee's Pharmaceutical Holdings هو A12CU5.

الرمز المُختصر لـ Lee's Pharmaceutical Holdings هو 950.HK.

خلال آخر 12 شهراً، دفعت Lee's Pharmaceutical Holdings توزيعات أرباح بقيمة ٠٫٠٢ HKD . وهذا يعادل عائد توزيعات أرباح يقارب ١٫٥٣ %. ومن المتوقع أن تدفع Lee's Pharmaceutical Holdings خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٠٫٠٢ HKD.

نسبة توزيعات الأرباح الحالية لـ Lee's Pharmaceutical Holdings هي ١٫٥٣ %.

Lee's Pharmaceutical Holdings يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أكتوبر, يونيو, أكتوبر, أكتوبر.

Lee's Pharmaceutical Holdings دفعت توزيعات الأرباح كل عام خلال الـ19 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٠٫٠٢ HKD. وهذا يعادل عائد توزيعات أرباح قدره ١٫٥٥ %.

Lee's Pharmaceutical Holdings يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة 0 HKD من Lee's Pharmaceutical Holdings المُعلن عنها في ٣‏/١٠‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ١٦‏/٩‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٣‏/١٠‏/٢٠٢٤.

في العام 2023، وزعت Lee's Pharmaceutical Holdings ٠٫٠٤١ HKD كأرباح أسهم.

يتم توزيع أرباح Lee's Pharmaceutical Holdings بالعملة HKD.